EnviTec Biogas adjusts planning for 2009 due to project postponements

Lohne, 20 October 2009 – According to preliminary figures, EnviTec Biogas AG [ISIN: DE000A0MVLS8] generated sales of about EUR 32 million in the third quarter of 2009, clearly more than in the first quarter (EUR 19.2 million) and in the second quarter (EUR 23.5 million). After the first three quarters of 2009, total sales amount to about EUR 74.7 million (previous year: EUR 64.5 million).

In spite of the favourable development in what has been a difficult year for the entire economy, the company has revised its sales projection and now expects full-year sales to grow from EUR 100.1 million to approximately EUR 110 million (originally EUR 150 - 200 million). Based on this, EnviTec anticipates reporting a balanced EBIT result (earnings before interest and taxes). The lower sales growth is due to the fact that contrary to original plans, the construction of several plants cannot be started before 2010. One of the reasons is that recent months have seen a substantial change in authorities’ approval policies to the detriment of plant engineering companies, particularly in Germany, which has led to sometimes considerable delays in project implementation in Germany but also abroad. Having impacted both plant sales and own plant operations, this development will shift a substantial sales volume. In addition, a number of projects, particularly in Eastern Europe, have incurred significant delays as a result of customers having to meet banks’ tightened lending standards.

Next year, EnviTec Biogas wants to continue its growth on a national and international level on the basis of the high order backlog. Orders on hand currently amount to about EUR 225 million, with 26% coming from abroad.

Investor Relations:
Olaf Brandes
EnviTec Biogas AG
Tel: +49 44 42 80 65-118
E-Mail: ir@envitec-biogas.de

Press Contact:
Fabian Lorenz, Christina Siebels
HOSCHKE & CONSORTEN Public Relations GmbH
Tel: +49 40 36 90 50- 56 /-58
E-Mail: f.lorenz@hoschke.de; c.siebels@hoschke.de